Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Press Release: Sanofi announces end of program evaluating tusamitamab ravtansine after a 2L NSCLC Phase 3 trial did not meet a primary endpoint
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Start of Day Message
-
IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
-
Corbion announces completion of its new circular lactic acid plant in Thailand
-
WISeKey and The Port Authority of Algeciras Join Forces in Pioneering Digital Transformation Project
-
WISeKey Subsidiaries, WISe.ART and SEALSQ, Partner with Paolina Art, artist Ylan Anoufa, and Clos de Lunes wines of Bordeaux, On Counterfeit Protection Venture
-
Results of Second Court Hearing
-
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
-
Schweiter Technologies strengthens its architecture business
-
Hepsor AS financial calendar 2024
-
Constellation Acquisition Corp I Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Ordinary Shares, Warrants and Units
-
GRAFTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating GrafTech International Ltd. on Behalf of GrafTech Stockholders and Encourages Investors to Contact the Firm
-
ARBOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Arbor Realty Trust, Inc. on Behalf of Arbor Stockholders and Encourages Investors to Contact the Firm
-
Wemade expands WEMIX PLAY ecosystem with the launch of blockchain games on LG screens
-
ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm
-
JAMES RIVER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against James River Group Holdings, Ltd. and Encourages Investors to Contact the Firm
-
SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
-
SOLAREDGE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SolarEdge Technologies, Inc. and Encourages Investors to Contact the Firm
-
ROCKLEY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rockley Photonics Holdings Limited and Encourages Investors to Contact the Firm
-
NATIONAL INSTRUMENTS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against National Instruments Corporation and Encourages Investors to Contact the Fi
-
PAYCOM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Paycom Software, Inc. and Encourages Investors to Contact the Firm
-
ROBLOX ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Roblox Corporation and Encourages Investors to Contact the Firm
-
LIVEPERSON ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against LivePerson, Inc. and Encourages Investors to Contact the Firm
-
LI-CYCLE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Li-Cycle, Corp. and Encourages Investors to Contact the Firm
-
FMC ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against FMC Corporation and Encourages Investors to Contact the Firm
-
DOCGO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DocGo, Inc. and Encourages Investors to Contact the Firm
-
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm
-
BARCLAYS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Barclays PLC and Encourages Investors to Contact the Firm
-
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Expensify, Inc. and Encourages Investors to Contact the Firm
-
EHANG ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against EHang Holdings Limited and Encourages Investors to Contact the Firm
-
CHARGEPOINT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against ChargePoint Holdings Inc. and Encourages Investors to Contact the Firm
-
BLUE RIDGE BANKSHARES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Blue Ridge Bankshares, Inc. and Encourages Investors to Contact the Firm
-
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
-
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm
-
Vanguard Announces Estimated Cash Distributions for the Vanguard ETFs (VAB, VSB, VSC, VLB, VCB, VGV, VRE, VDY, VCE, VCN, VFV, VSP, VUN, VUS, VGG, VGH, VE, VDU, VEF, VIU, VI, VEE, VA, VXC, VVO, VMO, V
-
Purpose Investments Inc. Announces 2023 Final Annual Income and Capital Gains Distributions
-
EFE Announces Festive Christmas Sale 2023 – Celebrate with Exclusive Eyewear Offers
-
Vanguard Investments Canada Announces Estimated 2023 Annual Capital Gains Distributions for the Vanguard ETFs®
-
PSB Holdings, Inc. announces semi-annual cash dividend of $0.30 per share
-
Tidewater Presents Charity Outing Proceeds to Food Bank of Delaware
-
The Chicago School President Michele Nealon Addresses Holiday Blues and Offers Tips for Improving Mental Health During This Holiday Season
-
Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders
-
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
-
Kering: Monthly statement on the total number of shares and voting rights (December 2023)
-
Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint
-
Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway
-
CAPREIT Announces $101MM in New Strategic Transactions
-
AutoZone Authorizes Additional Stock Repurchase


